Precision medicine

September 30, 2021

NCI-MATCH Eliminates the Need for a Formal Referral Letter from the Laboratories

Removing one of several steps will help speed the process for identifying patients who may be eligible to enroll for treatment in NCI-MATCH
July 7, 2021
TMIST recruitment graph

Trial Updates: TMIST Enrollment Hits 50,000; NCI-MATCH News; Recent Research Results

Recent ECOG-ACRIN trial updates and results
May 28, 2021
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, May 2021

Virtual Spring 2021 Group Meeting generates record attendance; screening and genomic trials return to full activity
April 27, 2021

Trial Spotlight: Search for patients intensifies with the opening of a new NCI-MATCH treatment arm

In this interview, Dr. Peter O'Dwyer urges physicians, sites, and testing laboratories to redouble efforts to locate patients for 12 open arms
January 25, 2021
Pink Rubik's cube

Joe Sparano: Refining Individual Risk in Breast Cancer

Dr. Sparano discusses the scientific and statistical collaboration behind a new tool, RSClin™, which integrates clinical–pathological and genomic risk information to guide adjuvant chemotherapy in node-negative breast cancer
October 19, 2020

Trial Results: Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks

The Journal of Clinical Oncology published new data from the NCI-MATCH precision medicine cancer trial that has broad relevance in medicine and provides a roadmap for future precision medicine trials
January 13, 2020
NCI-MATCH crowd silhouettes

NCI-MATCH (EAY131) Trial Update

A series of changes were recently incorporated in Addendum #24